| Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. WJ Grossman, JT Kimata, FH Wong, M Zutter, TJ Ley, L Ratner Proceedings of the National Academy of Sciences 92 (4), 1057-1061, 1995 | 423 | 1995 |
| CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection W Wang, C Ye, J Liu, D Zhang, JT Kimata, P Zhou PloS one 9 (12), e115987, 2014 | 250 | 2014 |
| Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression JT Kimata, LR Kuller, DB Anderson, P Dailey, J Overbaugh Nature medicine 5 (5), 535-541, 1999 | 234 | 1999 |
| Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones JT Kimata, FH Wong, JJ Wang, L Ratner Virology 204 (2), 656-664, 1994 | 158 | 1994 |
| Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid. ML Bryant, RO Heuckeroth, JT Kimata, L Ratner, JI Gordon Proceedings of the National Academy of Sciences 86 (22), 8655-8659, 1989 | 126 | 1989 |
| Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN F Baribaud, S Pöhlmann, T Sparwasser, MTY Kimata, YK Choi, ... Journal of virology 75 (21), 10281-10289, 2001 | 101 | 2001 |
| Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody … LM Rudensey, JT Kimata, EM Long, B Chackerian, J Overbaugh Journal of virology 72 (1), 209-217, 1998 | 101 | 1998 |
| SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice J Pollet, WH Chen, L Versteeg, B Keegan, B Zhan, J Wei, Z Liu, J Lee, ... Human vaccines & immunotherapeutics 17 (8), 2356-2366, 2021 | 90 | 2021 |
| Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific … BP Danielson, GE Ayala, JT Kimata The Journal of infectious diseases 202 (10), 1470-1477, 2010 | 79 | 2010 |
| Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population LM Rudensey, JT Kimata, RE Benveniste, J Overbaugh Virology 207 (2), 528-542, 1995 | 77 | 1995 |
| Challenges and strategies for the eradication of the HIV reservoir JT Kimata, AP Rice, J Wang Current opinion in immunology 42, 65-70, 2016 | 64 | 2016 |
| Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy Z Ambrose, S Palmer, VF Boltz, M Kearney, K Larsen, P Polacino, ... Journal of virology 81 (22), 12145-12155, 2007 | 62 | 2007 |
| The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway JT Kimata, TJ Palker, L Ratner Journal of virology 67 (6), 3134-3141, 1993 | 62 | 1993 |
| Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization JT Kimata, L Ratner Journal of virology 65 (8), 4398-4407, 1991 | 62 | 1991 |
| Integration of human immunodeficiency virus type 1 in untreated infection occurs preferentially within genes H Liu, EC Dow, R Arora, JT Kimata, LM Bull, RC Arduino, AP Rice Journal of virology 80 (15), 7765-7768, 2006 | 56 | 2006 |
| Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1 R Thippeshappa, P Polacino, MT Yu Kimata, EB Siwak, D Anderson, ... Journal of Virology 85 (8), 3767-3779, 2011 | 54 | 2011 |
| Replication of Zika virus in human prostate cells: a potential source of sexually transmitted virus JL Spencer, A Lahon, LL Tran, RP Arya, AR Kneubehl, MB Vogt, D Xavier, ... The Journal of infectious diseases 217 (4), 538-547, 2018 | 49 | 2018 |
| Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV‐challenged nonhuman primates FP Pons‐Faudoa, A Sizovs, KA Shelton, Z Momin, JA Niles, LR Bushman, ... Advanced therapeutics 4 (3), 2000163, 2021 | 46 | 2021 |
| Vpx is critical for SIVmne infection of pigtail macaques M Belshan, JT Kimata, C Brown, X Cheng, A McCulley, A Larsen, ... Retrovirology 9, 1-13, 2012 | 43 | 2012 |
| Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection S Auclair, F Liu, Q Niu, W Hou, G Churchyard, C Morgan, N Frahm, ... PLoS pathogens 14 (2), e1006888, 2018 | 40 | 2018 |
